Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Im Cannabis Closes Previously Announced Acquisition Of Oranim Pharm, Jerusalem'S Leading Medical Cannabis Pharmacy
Acquiring Company
IM Cannabis Corp
Acquired Company
Oranim Pharm
HerzliyaIsraelOtherManufacturingBiotechnologyFood and BeverageCommunity And LifestyleHealth CareMedicalCannabisDescription
IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, has completed the strategic acquisition of 51% of the rights in Oranim Pharm partnership ("Oranim Pharm"). Oranim Pharm is one of the largest pharmacies selling medical cannabis in Israel and the largest pharmacy selling medical cannabis in the Jerusalem area. The acquisition was completed through IMC Holdings Ltd. ("IMC Holdings"), a wholly-owned subsidiary of IM Cannabis Corp., following receipt of all requisite approvals, including from the Israeli Medical Cannabis Agency ("IMCA").
Fundz sees it the moment IM Cannabis Corp makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Oranim Pharm?
Oranim Pharm was acquired by IM Cannabis Corp, based in Herzliya. The deal was reported on March 30, 2022. IM Cannabis Corp. (IMC) is a leading medical cannabis company with operations in Israel and Germany. IM Cannabis Corp is publicly traded (IMCC) and operates in Other.
When did IM Cannabis Corp acquire Oranim Pharm?
IM Cannabis Corp's acquisition of Oranim Pharm was reported on March 30, 2022. IM Cannabis Corp. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Oranim Pharm do?
בית מרקחת אורנים פארם מתמחה באספקת קנאביס רפואי במרשם, משלוח קנאביס רפואי לבית הלקוח ומשלוח מגוון תרופות בהתאם למרשם. כנסו לאתר למידע נוסף. It is privately held, and is based in Israel.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.